Butylphthalide for Preventing Restenosis After Intracranial and Extracranial Artery Stenting

NCT01405248 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Restenosis

Interventions

DRUG: Butylphthalide
DRUG: Placebo

Sponsor

Jinling Hospital, China

Collaborators

[object Object]